ZHER2 Affibody as a Good Candidate for Detection of Metastatic Prostate Cancer

Authors

  • Mahboobeh Nazari Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  • Ramin Radmanesh Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

DOI:

https://doi.org/10.18502/ajmb.v13i3.6366

Keywords:

Prostate cancer, Positron Emission Tomography (PET), ZHER2 affibody

Abstract

The article abstract is not available.

Downloads

Published

2021-06-13

Issue

Volume (13) issue (3)

Section

Articles